LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $231,000 | -1.3% | 2,184 | -5.1% | 0.03% | +7.7% |
| Q4 2016 | $234,000 | -31.4% | 2,302 | -31.0% | 0.03% | -16.1% |
| Q3 2016 | $341,000 | -36.0% | 3,338 | -25.3% | 0.03% | -35.4% |
| Q2 2016 | $533,000 | -39.8% | 4,471 | -46.0% | 0.05% | -35.1% |
| Q1 2016 | $886,000 | -43.2% | 8,278 | -42.5% | 0.07% | -35.1% |
| Q4 2015 | $1,561,000 | -69.5% | 14,399 | -75.9% | 0.11% | -40.0% |
| Q3 2015 | $5,126,000 | – | 59,858 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |